Operator Greetings and welcome to the Cancer Genetics Second Quarter 2014 Earnings Conference Call. At this time all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. (Operator ... Seeking Alpha, 1 week ago
2 images for "Cgix"
Cancer Genetics, Inc. and Leading Pathologist From Keck Medicine of USC Collaborate to Evaluate and Optimize Genomic Panel for Lymphoma
RUTHERFORD, N.J., Aug. 25, 2014 (GLOBE NEWSWIRE) -- (Nasdaq:CGIX) ("CGI" or "The Company"), an emerging leader in DNA-based cancer diagnostics, and Keck Medicine of the University of Southern California (USC) pathologist Imran Siddiqi, M.D., Ph.D., ...Digital Producer, 2 days ago Cancer Genetics boosts Medicare coverage for DNA-based cancer Dx Fierce BioMarkers, 1 week ago Cancer Genetics Inc. Completes Acquisition of BioServe India, a Premier Genomics and Next-Generation Sequencing Company Benzinga.com, 1 week ago Cancer Genetics completes acquisition of BioServe India Hindu Business Line, 1 week ago
More from: Stock Nod, Stock Nod...and 59 other sources
Actavis plc (ACT: Quote) announced that the New Drug Application for Levosert, an investigational hormonal intrauterine contraceptive for use by women to prevent pregnancy, has been accepted for review by FDA. The regulatory agency is expected to ...RTTNews.com, 1 month ago
Allergan Inc. (AGN: Quote) is asking its shareholders to reject Valeant Pharmaceuticals International Inc.'s (VRX) (VRX.TO) buyout offer as it is grossly inadequate. The buyout offer allows Allergan stockholders to exchange each of their Allergan ...RTTNews.com, 2 months ago
Cancer Genetics (NASDAQ:CGIX) traded down 7.1% during trading on Thursday after the company announced weaker than expected quarterly earnings, reports. The company traded as low as $9.01 and last traded at $9.15, with a volume of 72,296 shares. The ...American Banking News, 1 week ago Cancer Genetics Rating Reiterated by Cantor Fitzgerald (CGIX) American Banking News, 1 week ago
Analysts are weighing in today on diagnostics specialist Cancer Genetics Inc (NASDAQ:CGIX), cloud software concern 2U Inc (NASDAQ:TWOU), and coffee company Keurig Green Mountain Inc (NASDAQ:GMCR). Here's a quick look at today's brokerage notes on ...Schaeffers Research, 1 week ago
Analysts Ratings Reiterations for August, 14th (BEAV, BRX, CGIX, CIDM, CIM, DE, EBSB, ENH, EPR, EZCH)
Analysts ratings reiterations for Thursday, August 14th: B/E Aerospace (NASDAQ:BEAV) Brixmor Property Group (NYSE:BRX) Cancer Genetics (NASDAQ:CGIX) Cinedigm Corp (NASDAQ:CIDM) Chimera Investment Corp. (NYSE:CIM) Deere & Company (NYSE:DE) ...American Banking News, 1 week ago
Cancer Genetics (NASDAQ:CGIX) issued its quarterly earnings data on Thursday. The company reported ($0.50) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.37) by $0.13, StockRatingsNetwork reports. The company had revenue ...American Banking News, 1 week ago Cancer Genetics EPS of -$0.50 Seeking Alpha, 1 week ago
Visit StreetInsider.com at http://www.streetinsider.com/news.php-st=p&id=9752403 for theWall Street Business Network, 1 week ago Cancer Genetics, Inc. (CGIX) to Acquire Gentris Corporation in $4.75M Deal Crawford Financial Planning, 2 months ago
More from: , TVNewsCheck...and 3 other sources
(M&A Navigator via COMTEX News Network) -- US DNA-based cancer diagnostics company Cancer Genetics Inc (NASDAQ:CGIX) said it had agreed to purchase genomics services provider and molecular kit manufacturer BioServe Biotechnologies (India) Pvt Ltd ...PredictWallStreet, 3 weeks ago
on your WebpageAdd Widget >Get your members hooked!